raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:623615

Autoimmune limbic encephalitis

Synonyms: ALE

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare autoimmune encephalitis involving the mesial temporal lobes and clinically characterized by subacute onset (i. e. rapid progression of less than three months) of short-term memory deficits, seizures or psychiatric symptoms, such as behavioral changes, anxiety, depression, and psychosis. Further diagnostic criteria are bilateral abnormalities restricted to the mesial temporal lobes in brain MRI, cerebrospinal fluid pleocytosis and/or epileptic or slow-wave activity involving the temporal lobes in EEG, and reasonable exclusion of alternative causes. Paraneoplastic or non-paraneoplastic antibodies against neuronal antigens may be found in serum and/or cerebrospinal fluid.

1

Names in Orphadata languages

10 of 12 languages
LangNameSynonyms
enAutoimmune limbic encephalitisALE
frEncéphalite limbique auto-immune
deAutoimmune limbische Enzephalitis= en
esEncefalitis límbica autoinmune
itEncefalite limbica autoimmune= en
nlAuto-immune limbische encefalitis= en
ptEncefalite límbica autoimune= en
plAutoimmunologiczne zapalenie układu limbicznego mózgu= en
csAutoimunitní limbická encefalitida= en
ukАутоімунний лімбічний енцефаліт= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10G04.8NTBTattributedvalidated
ICD-118E4A.0NTBTindexvalidated
MONDO0850097Evalidated
MeSHC531729Evalidated
UMLSC2930824Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0001.7 / 100 000EuropeValue and classValidated31552550[PMID]_ORPHANET
Annual incidence1-9 / 1 000 0000.25 / 100 000EuropeValue and classValidated31552550[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

24 annotations · validated 2024-10-09
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0012658Abnormal brain FDG positron emission tomographyDiagnostic criterion
HP:5000016Anti-Hu antibody positivity
HP:5000020Anti-LGI1 antibody
HP:0000739Anxiety
HP:0000708Atypical behavior
HP:6000397CSF oligoclonal immunoglobulin G bands
HP:0012229CSF pleocytosisDiagnostic criterion
HP:0000716Depression
HP:0010843EEG with focal slow activityDiagnostic criterion
HP:6001115EEG with temporal slowingDiagnostic criterion
HP:0001945Fever
HP:0002315Headache
HP:0002922Increased CSF protein concentration
HP:0000737Irritability
HP:0001254Lethargy
HP:0001268Mental deterioration
HP:0000709Psychosis
HP:0001250Seizure
HP:0033687Short term memory impairment
Occasional (29-5%)
HP:5000005Anti-CASPR2
HP:5000010Anti-GABA(B)R antibody
HP:0010532Paroxysmal vertigo
Excluded (0%)
HP:0002383Infectious encephalitisDiagnostic criterion
HP:0100836Malignant neoplasm of the central nervous systemDiagnostic criterion

Annotation source: 31085562[PMID]_34603897[PMID]_26906964[PMID]_30421340[PMID]

7

Sources for this card